Related references
Note: Only part of the references are listed.Desferrithiocin analogue iron chelators: iron clearing efficiency, tissue distribution, and renal toxicity
Raymond J. Bergeron et al.
BIOMETALS (2011)
Synthesis, physical-chemical characterisation and biological evaluation of novel 2-amido-3-hydroxypyridin-4(1H)-ones: Iron chelators with the potential for treating Alzheimer's disease
Alessandra Gaeta et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Synthesis, iron(III)-binding affinity and in vitro evaluation of 3-hydroxypyridin-4-one hexadentate ligands as potential antimicrobial agents
Bo Xu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
In vitro inhibition of bacterial growth by iron chelators
Di-Hong Qiu et al.
FEMS MICROBIOLOGY LETTERS (2011)
A phase 1 dose-escalation study: safety, tolerability, and pharmacokinetics of FBS0701, a novel oral iron chelator for the treatment of transfusional iron overload
Hugh Young Rienhoff et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Clinically available iron chelators induce neuroprotection in the 6-OHDA model of Parkinson's disease after peripheral administration
David T. Dexter et al.
JOURNAL OF NEURAL TRANSMISSION (2011)
Design of clinically useful macromolecular iron chelators
Tao Zhou et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2011)
The potential application of iron chelators for the treatment of neurodegenerative diseases
Robert C. Hider et al.
METALLOMICS (2011)
CHARGE STATES OF DEFERASIROX-FERRIC IRON COMPLEXES
Robert C. Hider
AMERICAN JOURNAL OF KIDNEY DISEASES (2010)
Combined iron chelation therapy
Renzo Galanello et al.
COOLEY'S ANEMIA: NINTH SYMPOSIUM (2010)
Monitoring the efficiency of iron chelation therapy: the potential of nontransferrin-bound iron
R. C. Hider et al.
COOLEY'S ANEMIA: NINTH SYMPOSIUM (2010)
The effect of deferasirox on cardiac iron in thalassemia major: impact of total body iron stores
John C. Wood et al.
BLOOD (2010)
Increased survival and reversion of iron-induced cardiac disease in patients with thalassemia major receiving intensive combined chelation therapy as compared to desferoxamine alone
Maria Eliana Lai et al.
BLOOD CELLS MOLECULES AND DISEASES (2010)
Amido-3-hydroxypyridin-4-ones as Iron(III) Ligands
Sirivipa Piyamongkol et al.
CHEMISTRY-A EUROPEAN JOURNAL (2010)
Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias
Maria Domenica Cappellini et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Chemistry and biology of siderophores
Robert C. Hider et al.
NATURAL PRODUCT REPORTS (2010)
Identification of a new hexadentate iron chelator capable of restricting the intramacrophagic growth of Mycobacterium avium
Sofia Sousa Fernandes et al.
MICROBES AND INFECTION (2010)
Design and synthesis of fluorine-substituted 3-hydroxypyridin-4-ones
Yong Min Ma et al.
TETRAHEDRON LETTERS (2010)
Mechanisms for the shuttling of plasma non-transferrin-bound iron (NTBI) onto deferoxamine by deferiprone
Patricia Evans et al.
TRANSLATIONAL RESEARCH (2010)
Fanconi Syndrome Due to Deferasirox
Cedric Rafat et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2009)
Influence of non-enzymatic post-translation modifications on the ability of human serum albumin to bind iron Implications for non-transferrin-bound iron speciation
Andre M. N. Silva et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2009)
Determination of the pKa value of the hydroxyl group in the α-hydroxycarboxylates citrate, malate and lactate by 13C NMR: implications for metal coordination in biological systems
Andre M. N. Silva et al.
BIOMETALS (2009)
Siderophores as drug delivery agents: application of the Trojan Horse strategy
Ute Moellmann et al.
BIOMETALS (2009)
Long-term sequential deferiprone-deferoxamine versus deferiprone alone for thalassaemia major patients: a randomized clinical trial
Aurelio Maggio et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Medicinal Inorganic Chemistry Approaches to Passivation and Removal of Aberrant Metal Ions in Disease
Lauren E. Scott et al.
CHEMICAL REVIEWS (2009)
Iron(III) citrate speciation in aqueous solution
Andre M. N. Silva et al.
DALTON TRANSACTIONS (2009)
Fenton chemistry and oxidative stress mediate the toxicity of the β-amyloid peptide in a Drosophila model of Alzheimer's disease
Thomas Rival et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2009)
Chelator-facilitated removal of iron from transferrin: relevance to combined chelation therapy
Lakshmi D. Devanur et al.
BIOCHEMICAL JOURNAL (2008)
Cell functions impaired by frataxin deficiency are restored by drug-mediated iron relocation
Or Kakhlon et al.
BLOOD (2008)
Targeting multiple Alzheimer's disease etiologies with multimodal neuroprotective and neurorestorative iron chelators
Tamar Amit et al.
FASEB JOURNAL (2008)
Potentiometric, spectrophotometric and calorimetric study on iron(III) and copper(II) complexes with 1,2-dimethyl-3-hydroxy-4-pyridinone
Valeria M. Nurchi et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2008)
Neuroprotective actions of deferiprone in cultured cortical neurones and SHSY-5Y cells
Francisco Molina-Holgado et al.
JOURNAL OF NEUROCHEMISTRY (2008)
The Fenton activity of iron(III) in the presence of deferiprone
Lakshmi D. Devanur et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Regression of symptoms after selective iron chelation therapy in a case of neurodegeneration with brain iron accumulation
Gian Luca Forni et al.
MOVEMENT DISORDERS (2008)
Iron chelation beyond transfusion iron overload
Antonello Pietrangelo
AMERICAN JOURNAL OF HEMATOLOGY (2007)
The iron chelator deferasirox protects mice from mucormycosis through iron starvation
Ashraf S. Ibrahim et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Selective iron chelation in Friedreich ataxia:: biologic and clinical implications
Nathalie Boddaert et al.
BLOOD (2007)
A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease
Elliott Vichinsky et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Action of chelators in iron-loaded cardiac cells: accessibility to intracellular labile iron and functional consequences
Hava Glickstein et al.
BLOOD (2006)
(S)-4,5-dihydro-2-( 2-hydroxy-4-hydroxyphenyl)-4-methyl-4-thiazolecarboxylic acid polyethers:: A solution to nephrotoxicity
RJ Bergeron et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis
DJ Pennell et al.
BLOOD (2006)
Chelator-induced dispersal and killing of Pseudomonas aeruginosa cells in a biofilm
E Banin et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2006)
The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy
A Gaeta et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Desketoneoenactin-siderophore conjugates for Candida : Evidence of iron transport-dependent species selectivity
G Bernier et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lession in rats
D Ben Shachar et al.
NEUROPHARMACOLOGY (2004)
Redox properties of the iron complexes of orally active iron chelators CP20, CP502, CP509, and ICL670
M Merkofer et al.
HELVETICA CHIMICA ACTA (2004)
Complex formation of ICL670 and related ligands with FeIII and FeII
S Steinhauser et al.
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2004)
Molecular shuttle chelation: The use of ascorbate, desferrioxamine and Feralex-G in combination to remove nuclear bound aluminum
TP Kruck et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2004)
Purging iron from the heart
C Hershko et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Current status of metals as therapeutic targets in Alzheimer's disease
AE Finefrock et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2003)
Role of deferiprone in chelation therapy for transfusional iron overload
AV Hoffbrand et al.
BLOOD (2003)
Safety, tolerability, and pharmacokinetics of ICL670, a new orally active iron-chelating agent in patients with transfusion-dependent iron overload due to β-thalassemia
R Galanello et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2003)
The metallobiology of Alzheimer's disease
AI Bush
TRENDS IN NEUROSCIENCES (2003)
Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: A novel therapy for Parkinson's disease
D Kaur et al.
NEURON (2003)
A novel trivalent cation chelator Feralex dissociates binding of aluminum and iron associated with hyperphosphorylated τ of Alzheimer's disease
RW Shin et al.
BRAIN RESEARCH (2003)
Rational design of sequestering agents for plutonium and other actinides
AEV Gorden et al.
CHEMICAL REVIEWS (2003)
The safety and effectiveness of deferiprone in a large-scale, 3-year study in Italian patients
A Ceci et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Protective effects of the sickle cell gene against malaria morbidity and mortality
M Aidoo et al.
LANCET (2002)
The distribution of the anti-HIV drug, 2′3′-dideoxycytidine (ddC), across the blood-brain and blood-cerebrospinal fluid barriers and the influence of organic anion transport inhibitors
JE Gibbs et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Design, synthesis, and evaluation of novel 2-substituted 3-hydroxypyridin-4-ones: Structure-activity investigation of metalloenzyme inhibition by iron chelators
ZD Liu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Synthesis of feralex a novel aluminum/iron chelating compound
TPA Kruck et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2002)
Synthesis and physicochemical assessment of novel 2-substituted 3-hydroxypyridin-4-ones, novel iron chelators
MY Moridani et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2002)
Deferiprone versus deferoxamine in patients with thalassemia major: A randomized clinical trial
A Maggio et al.
BLOOD CELLS MOLECULES AND DISEASES (2002)
Treatment of Alzheimer's disease with clioquinol
B Regland et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2001)
Treatment with a copper-zinc chelator markedly and rapidly inhibits β-amyloid accumulation in Alzheimer's disease transgenic mice
RA Cherny et al.
NEURON (2001)
ICL670A: a new synthetic oral chelator: evaluation in hypertransfused rats with selective radioiron probes of hepatocellular and reticuloendothelial iron stores and in iron-loaded rat heart cells in culture
C Hershko et al.
BLOOD (2001)
Synthesis and biological studies of glycosyl dopamine derivatives as potential antiparkinsonian agents
C Fernández et al.
CARBOHYDRATE RESEARCH (2000)
Enkephalin glycopeptide analogues produce analgesia with reduced dependence liability
EJ Bilsky et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Improving the oral bioavailability of the iron chelator HBED by breaking the symmetry of the intramolecular H-bond network
B Faller et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Systemically administered D-glucose conjugates of 7-chlorokynurenic acid are centrally available and exert anticonvulsant activity in rodents
G Battaglia et al.
BRAIN RESEARCH (2000)
Iron and citric acid: A fuzzy chemistry of ubiquitous biological relevance
JL Pierre et al.
BIOMETALS (2000)
Share Paper
